Glenmark Pharmaceuticals Ltd

About [ edit ]

Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacture and marketing of pharmaceutical products.(Source : 202003-01 Annual Report Page No:138)

  • Market Cap 17,140 Cr.
  • Current Price 607
  • High / Low 691 / 442
  • Stock P/E 10.8
  • Book Value 525
  • Dividend Yield 0.41 %
  • ROCE 12.1 %
  • ROE 11.3 %
  • Face Value 1.00

Pros

  • Stock is trading at 1.16 times its book value
  • Company's median sales growth is 18.04% of last 10 years

Cons

  • The company has delivered a poor sales growth of 4.36% over past five years.
  • Company has a low return on equity of 11.32% for last 3 years.
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
1,406 1,680 1,632 1,587 1,499 1,790 1,816 1,608 1,683 2,062 1,972 1,850
1,088 1,288 1,283 1,319 1,190 1,409 1,403 1,406 1,174 1,567 1,442 1,494
Operating Profit 318 392 349 269 309 381 414 202 509 495 530 356
OPM % 23% 23% 21% 17% 21% 21% 23% 13% 30% 24% 27% 19%
Other Income 228 616 -58 168 69 192 94 270 163 63 127 117
Interest 55 61 55 53 68 65 60 64 60 60 83 63
Depreciation 27 27 26 26 32 33 38 35 36 37 41 37
Profit before tax 463 921 210 358 277 475 411 373 576 462 533 373
Tax % 14% 19% 7% 21% 18% 9% 16% 6% 20% 13% 17% 8%
Net Profit 397 748 196 281 228 432 346 349 462 403 442 342
EPS in Rs 14.08 26.49 6.94 9.97 8.07 15.31 12.25 12.38 16.39 14.28 15.68 12.11

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
983 1,163 1,565 1,949 2,301 5,086 6,115 7,989 5,520 6,305 6,713 7,568
819 877 1,253 1,617 1,805 3,618 4,349 5,089 4,417 4,977 5,408 5,678
Operating Profit 164 286 311 332 496 1,467 1,766 2,900 1,103 1,327 1,304 1,890
OPM % 17% 25% 20% 17% 22% 29% 29% 36% 20% 21% 19% 25%
Other Income 78 72 55 116 67 -86 116 -89 326 955 625 470
Interest 100 86 61 44 31 30 36 153 191 224 256 266
Depreciation 21 21 21 25 30 119 100 105 96 106 139 151
Profit before tax 121 251 284 380 502 1,232 1,747 2,553 1,143 1,952 1,535 1,944
Tax % -6% 15% 7% -2% 14% 18% 15% 16% 11% 17% 12% 15%
Net Profit 128 212 265 386 434 1,008 1,484 2,141 1,014 1,622 1,355 1,649
EPS in Rs 4.76 7.85 9.81 14.25 15.99 37.14 52.60 75.86 35.95 57.49 48.01 58.46
Dividend Payout % 8% 5% 20% 14% 12% 5% 4% 3% 6% 3% 5% 4%
Compounded Sales Growth
10 Years:21%
5 Years:4%
3 Years:11%
TTM:13%
Compounded Profit Growth
10 Years:22%
5 Years:1%
3 Years:16%
TTM:19%
Stock Price CAGR
10 Years:7%
5 Years:-6%
3 Years:1%
1 Year:34%
Return on Equity
10 Years:15%
5 Years:14%
3 Years:11%
Last Year:11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
27 27 27 27 27 27 28 28 28 28 28 28
Reserves 1,746 1,953 2,159 2,496 2,879 4,925 7,338 9,408 10,363 11,914 13,198 14,781
Borrowings 760 1,143 489 581 353 410 787 2,777 2,981 3,134 3,574 3,626
234 251 494 782 970 2,289 1,960 1,787 1,892 2,066 2,152 2,182
Total Liabilities 2,767 3,374 3,169 3,886 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618
190 224 224 276 449 1,231 1,438 1,596 1,699 1,413 1,612 1,761
CWIP 47 34 69 172 83 294 276 271 420 286 200 93
Investments 993 1,041 1,083 1,294 1,409 1,660 1,858 1,867 3,213 3,269 4,714 6,990
1,537 2,076 1,793 2,143 2,289 4,466 6,541 10,267 9,933 12,174 12,426 11,774
Total Assets 2,767 3,374 3,169 3,886 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
983 421 195 253 114 145 355 878 1,124 2,490 1,579 1,243
-1,000 -655 602 -119 211 -176 -1,545 -2,580 -1,137 -2,256 -1,607 -1,235
10 259 -780 -14 -385 -32 1,223 1,879 -62 -155 -139 -81
Net Cash Flow -7 26 16 120 -60 -64 32 177 -75 79 -168 -73

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
ROCE % 9% 12% 12% 15% 17% 33% 26% 29% 10% 13% 11% 12%
Debtor Days 123 59 84 104 180 175 182 177 253 121 100 120
Inventory Turnover 2.07 2.28 2.64 3.07 3.15 3.74 2.41 2.41 1.90 2.41 3.15 3.75

Shareholding Pattern

Numbers in percentages

Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
46.54 46.54 46.54 46.58 46.58 46.59 46.62 46.62 46.63 46.63 46.63 46.63
30.90 32.27 32.62 31.04 31.37 30.16 28.51 23.40 25.79 26.48 25.84 26.82
7.29 6.93 6.93 7.68 7.43 7.04 6.75 5.53 4.46 9.43 9.16 9.73
15.28 14.26 13.90 14.71 14.62 16.21 18.12 24.44 23.13 17.46 18.38 16.82

Documents